1E Therapeutics

1E Therapeutics is a groundbreaking drug development company that develops first-class RNA-targeted therapies based on a proprietary drug design platform. The pioneering process of 1E Therapeutics has demonstrated a unique ability to develop innovative drugs to address life-threatening chronic conditions as well as emerging and evolving pathogens. 1E Therapeutics already possesses lead compounds that can address various indications, including oncology, age-related diseases, immunology, antimicrobial resistance, viral infections, and orphan neurological disorders.